Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation …

JP van Meerbeeck, R Gaafar, C Manegold… - Journal of Clinical …, 2005 - ascopubs.org
Purpose We conducted a phase III trial to determine whether first-line treatment with
raltitrexed, a thymidine synthase inhibitor, and cisplatin results in superior outcome …

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation …

JP van Meerbeeck, R Gaafar… - Journal of clinical …, 2005 - repository.uantwerpen.be
Purpose We conducted a phase III trial to determine whether first-line treatment with
raltitrexed, a thymidine synthase inhibitor, and cisplatin results in superior outcome …

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European …

JP van Meerbeeck, R Gaafar, C Manegold… - Journal of Clinical …, 2005 - dial.uclouvain.be
Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant
Pleural Mesothelioma : An Intergroup Study of the European Organisation for Research and …

[引用][C] Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the european …

JP VAN MEERBEECK, R GAAFAR… - Journal of clinical …, 2005 - pascal-francis.inist.fr
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant
pleural mesothelioma : An intergroup study of the european organisation for research and …

[PDF][PDF] Jan P. van Meerbeeck, Rabab Gaafar, Christian Manegold, Rob J. Van Klaveren, Eric A. Van Marck

M Vincent, C Legrand, A Bottomley, C Debruyne… - J Clin …, 2005 - researchgate.net
Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant
Pleural Mesothelioma: An Intergro Page 1 Randomized Phase III Study of Cisplatin With or …

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European organisation …

J van Meerbeeck, R Gaafar, C Manegold… - Journal of Clinical …, 2005 - repub.eur.nl
Purpose: We conducted a phase III trial to determine whether first-line treatment with
raltitrexed, a thymidine synthase inhibitor, and cisplatin results in superior outcome …

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European …

JP van Meerbeeck, R Gaafar, C Manegold… - Journal of Clinical …, 2005 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> We conducted a phase III trial to
determine whether first-line treatment with raltitrexed, a thymidine synthase inhibitor, and …

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation …

J Van Meerbeeck, R GAAFAR… - JOURNAL OF …, 2005 - biblio.ugent.be
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant
pleural mesothelioma: An intergroup study of the European Organisation for Research and …

[PDF][PDF] Jan P. van Meerbeeck, Rabab Gaafar, Christian Manegold, Rob J. Van Klaveren, Eric A. Van Marck

M Vincent, C Legrand, A Bottomley, C Debruyne… - J Clin Oncol, 2005 - academia.edu
Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant
Pleural Mesothelioma: An Intergro Page 1 Randomized Phase III Study of Cisplatin With or …

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation …

JP van Meerbeeck, R Gaafar, C Manegold… - Journal of Clinical …, 2005 - europepmc.org
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant
pleural mesothelioma: an intergroup study of the European Organisation for Research and …